Abstract:We investigated commercially available dermal sheep collagen either cross-linked with hexamethylenediisocyanate, or cross-linked with glutaraldehyde. In previous in vitro studies we could discriminate primary, i.e. extractable, and secondary cytotoxicity, due to cell-biomaterial interactions, i.e. enzymatic actions. To develop dermal sheep collagen for clinical applications, we focused in this study on the release, e.g. elimination, of secondary cytotoxicity over time. We used the universal 7 d methylcellulose cell culture with human skin fibroblasts as a test system. Hexamethylenediisocyanate-cross-linked dermal sheep collagen and glutaraldehyde-cross-linked dermal sheep collagen were tested, with intervals of 6 d, over a culture period of 42 d. With hexamethylenediisocyanate-cross-linked dermal sheep collagen, cytotoxicity, i.e. cell growth inhibition and deviant cell morphology, was eliminated after 18 d of exposure. When testing glutaraldehyde-cross-linked dermal sheep collagen, the bulk of cytotoxic products was released after 6 d, but a continuous low secondary cytotoxicity was measured up to 42 d. As a control, non-cross-linked dermal-sheep collagen was tested over a period of 36 d, but no secondary cytotoxic effects were observed. The differences in release of secondary cytotoxicity between hexamethylenediisocyanate-cross-linked dermal sheep collagen, glutaraldehyde-cross-linked dermal sheep collagen and non-cross-linked dermal sheep collagen are explained from differences in cross-linking agents and cross-links obtained. We hypothesize that secondary cytotoxicity results from enzymatic release of pendant molecules from hexamethylene-diisocyanate-cross-linked dermal sheep collagen, e.g. formed after reaction of hydrolysis products of hexamethylenediisocyanate with dermal sheep collagen. Glutaraldehyde-cross-linked dermal sheep collagen contains residual cross-linking agents, which induce the bulk cytotoxicity. Apart from being sensitive to enzymatic degradation, glutaraldehyde-cross-linked dermal sheep collagen was also found to be sensitive to aqueous hydrolysis. Hydrolysis of cross-links may release cytotoxic products and introduce new pendant molecules within glutaraldehyde-cross-linked dermal sheep collagen, which in turn induce cytotoxicity after enzymatic attack.

Biocompatibility And Tissue Regenerating Capacity Of Cross-Linked Dermal Sheep Collagen

Characterization and Biocompatibility of Epoxy-Crosslinked Dermal Sheep Collagens

Relations Between Invitro Cytotoxicity and Cross-Linked Dermal Sheep Collagens

Tissue Regenerating Capacity of Carbodiimide-Crosslinked Dermal Sheep Collagen During Repair of the Abdominal Wall

Tissue Interactions With Dermal Sheep Collagen Implants - A Transmission Electron-Microscopic Evaluation

Crosslinking and modification of dermal sheep collagen using 1, 4-butanediol diglycidyl ether.

Calcification of Subcutaneously Implanted Collagens in Relation to Cytotoxicity, Cellular Interactions and Crosslinking

Cross-linking of Dermal Sheep Collagen Using a Water-Soluble Carbodiimide.

Successive epoxy and carbodiimide cross-linking of dermal sheep collagen.

In Vivo Interactions with (tissue Culture Pretreated) Dermal Sheep Collagen

Crosslinking of dermal sheep collagen using hexamethylene diisocyanate

In vivo degradation of processed dermal sheep collagen evaluated with transmission electron microscopy

Three Types of Dermal Grafts in Rats: the Importance of Mechanical Property and Structural Design.

Enzyme-Pretreatment RemovesIn VitroCytoxic Effects of Dermal Sheep Collagen

Secondary Cytotoxicity of Cross-Linked Dermal Sheep Collagens During Repeated Exposure to Human Fibroblasts

Covalently crosslinked human-like collagen hydrogel: Properties of biocompatibility

In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: Effects of crosslink density, heparin immobilization, and bFGF loading.

Changes in the mechanical properties of dermal sheep collagen duringin vitro degradation

[Design and Biological Evaluation of Poly-Lactic-co-glycolic Acid (PLGA) Mesh/collagen-Chitosan Hybrid Scaffold (CCS) As a Dermal Substitute].

Study the Biodegradation of a Injection Human-Like Collagen Hydrogel

Evaluation of an Amniotic Membrane-Collagen Dermal Substitute in the Management of Full-Thickness Skin Defects in a Pig